Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324752 · ClinicalTrials.gov registry record · Phase 1
A Drug-Drug Interaction Study of Losartan and PA21
A Phase 1 study, sponsored by Vifor Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01324752: Completed Phase 1 study, sponsored by Vifor Pharma.
NCT01324752 is a Phase 1 study that has completed, run by Vifor Pharma. The registered enrollment target is 36 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01324752, a Phase 1 study, has completed, sponsored by Vifor Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Losartan potassium is affected by PA21.
Primary Outcome
To assess the effect, if any, of PA21 on Losartan potassium exposure
Interventions
- DRUG PA21 and Losartan with Food
- DRUG No PA21; Losartan with food
- DRUG PA21 with food and Losartan 2 hours later
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
What the finished NCT01324752 record still lists
NCT01324752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 3 interventions - of which PA21 and Losartan with Food is the first listed.
NCT01324752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01324752 about?
NCT01324752 is a clinical study titled "A Drug-Drug Interaction Study of Losartan and PA21". The purpose of this study is to determine if Losartan potassium is affected by PA21.
What is the current status of trial NCT01324752?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2011-03. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01324752?
The interventions under investigation include: PA21 and Losartan with Food (DRUG), No PA21; Losartan with food (DRUG), PA21 with food and Losartan 2 hours later (DRUG).
Who is sponsoring clinical trial NCT01324752?
This trial is sponsored by Vifor Pharma, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01324752's enrollment target sits among peer trials
36 1210th of 2000 higher than 743 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia